Add like
Add dislike
Add to saved papers

Clinicopathological characteristics and outcomes of renal sarcoidosis: A series study of 18 patients from a single center.

Nephron 2023 April 20
INTRODUCTION: Sarcoidosis is characterized by non-caseating granulomatous inflammation in multiple organs. Renal involvement is rare, and granulomatous tubulointerstitial nephritis (GIN) is the predominant histologic feature. Renal sarcoidosis (RS) is usually diagnosed by exclusion, combining clinical and histological findings, and often remains misdiagnosed. This retrospective study aimed to describe the characteristics and prognosis of patients with RS in China.

METHODS: 18 patients with RS from a single center were enrolled, of whom 15 had biopsy-proven tubulointerstitial nephritis. Their clinicopathological features and renal outcomes were analyzed to understand this rare disease better.

RESULTS: 18 patients (14 male/4 female) were included in our study. The median eGFR was 30.36 (11.57, 60.14) ml/min/1.73m2. In 15 patients undergoing a renal biopsy, GIN was the most common pathological phenotype (66.67%). 17 patients had follow-up records, with a median follow-up of 24.07 (8.82, 60.90) months. One month after treatment, median estimated glomerular filtration rate (eGFR) increased significantly from 30.36 (11.57, 60.14) ml/min/1.73m2 to 58.53(39.35, 80.65) ml/min/1.73m2, and proteinuria decreased from 1.10 (0.69, 1.58) g/24h to 0.68 (0.52, 1.05) g/24h. No patients relapsed or developed end-stage renal disease.

CONCLUSION: RS is a rare but important cause of tubulointerstitial injury, with a favorable long-term prognosis if properly diagnosed and treated promptly.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app